| Literature DB >> 31397261 |
A F Jorm1, A J Mackinnon1,2, L M Hart1, N J Reavley1, A J Morgan1.
Abstract
AIMS: The prevalence of common mental disorders has not declined in high-income countries despite substantial increases in service provision. A possible reason for this lack of improvement is that greater willingness to disclose mental disorders might have led to increased reporting of psychiatric symptoms, thus masking reductions in prevalence. This masking hypothesis was tested using data from two trials of interventions that increased willingness to disclose and that also measured symptoms. Both interventions involved Mental Health First Aid (MHFA) training, which is known to reduce stigma, including unwillingness to disclose a mental health problem.Entities:
Keywords: Adolescents; attitudes; common mental disorders; mental health; stigma
Mesh:
Year: 2019 PMID: 31397261 PMCID: PMC8061127 DOI: 10.1017/S2045796019000404
Source DB: PubMed Journal: Epidemiol Psychiatr Sci ISSN: 2045-7960 Impact factor: 6.892
Fig. 1.Cross-lagged model of willingness to disclose a mental disorder (Disclose) and K6 score in adolescents. (Paths from Group are standardised coefficients for dependent variable only: all others are fully standardised. *: p < 0.05; ** p < 0.01 established from bootstrap confidence intervals.)
Fig. 2.Cross-lagged model of willingness to disclose mental disorder (Disclose) and K6 score in adults. (Paths from Group are standardised coefficients for dependent variable only: all others are fully standardised. * p < 0.05; ** p < 0.01 established from bootstrap confidence intervals.)
Descriptive statistics for willingness to disclose and K6 for each occasion of measurement by trial and intervention status
| Willingness to disclose | |||
| Control | 3.51 (0.96) | 3.52 (0.98) | 3.44 (0.95) |
| MHFA | 3.61 (0.96) | 3.89 (0.90) | 3.73 (0.88) |
| K6 Total score | |||
| Control | 13.82 (5.47) | — | 13.89 (5.28) |
| MHFA | 13.27 (5.23) | — | 13.36 (5.05) |
| Willingness to disclose | |||
| Control | 4.17 (0.75) | 4.06 (0.90) | 4.18 (0.78) |
| MHFA | 4.11 (0.79) | 4.33 (0.60) | 4.26 (0.72) |
| K6 Total score | |||
| Control | 14.02 (5.97) | — | 14.20 (6.35) |
| MHFA | 13.78 (5.79) | — | 13.43 (6.10) |
Total effects of baseline status on outcomes in the adolescent MHFA trial
| Outcome | Predictor | Standardised effect | 95% CI |
|---|---|---|---|
| Willingness to disclose (Time 3) | |||
| Willingness to disclose (Time 1) | 0.40** | 0.33–0.47 | |
| K6 (Time 1) | −0.05 | −0.12–0.02 | |
| Group (MHFA | 0.14** | 0.08–0.20 | |
| K6 (Time 3) | |||
| Willingness to disclose (Time 1) | −0.09** | −0.15 to −0.03 | |
| K6 (Time 1) | 0.55** | 0.49–0.60 | |
| Group (MHFA | −0.02 | −0.08–0.02 |
* p < 0.05; ** p < 0.01.
Total effects of baseline status on outcomes in adult the MHFA trial
| Outcome | Predictor | Standardised effect | 95% CI |
|---|---|---|---|
| Willingness to disclose (Time 3) | |||
| Willingness to disclose (Time 1) | 0.52** | 0.40–0.62 | |
| K6 (Time 1) | 0.05 | −0.06–0.16 | |
| Group (MHFA | 0.11* | 0.01–0.22 | |
| K6 (Time 3) | |||
| Willingness to disclose (Time 1) | −0.06 | −0.15–0.03 | |
| K6 (Time 1) | 0.61** | 0.49–0.60 | |
| Group (MHFA | −0.05 | −0.14–0.04 | |
* p < 0.05; ** p < 0.01.